Drug Trial Radar · NCT05418244
Inhaled Isopropyl Alcohol for Treatment of Nausea
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
84
Planned (sponsor's estimate)
Start
Apr 20, 2022
Primary completion
Jun 30, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- State University of New York at BuffaloAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 7 years, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
Conditions
- Vomiting
- Nausea
- Children, Only
Interventions
Inhaled Isopropyl AlcoholOther
Isopropyl alcohol pad (Covidien Webcol 2 ply prep pads, saturated with 70% isopropyl alcohol) held 1-2 cm under the subject's nares
Oral OndansetronDrug
4 mg oral disintegrating ondansetron tablet once
Inhaled PlaceboOther
Normal saline pad (Hygea sterile saline wipe) held 1-2 cm under the subject's nares
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Nausea Score at 30 MinutesTime frame: 30 minutes post-intervention as compared to baseline
- Change in Nausea Score at 10 MinutesTime frame: 10 minutes post-interventnon as compared to baseline
- Change in Nausea Score at DischargeTime frame: At ED discharge (assessed up to 10 hours) as compared to baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oishei Children's Hospital
Buffalo, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.